NSN 6505-01-278-1124 · NIIN 012781124 · FSC 6505
NO DASHES 6505012781124
In Stock
ETOPOSIDE CAPSULES
Drugs and Biologicals
Technical characteristics
6 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| AJCN | PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS ETOPOSIDE ACTIVE INGREDIENT 50.000 |
| CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |
| CQCT | PRIMARY CONTAINER TYPE | STRIP |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ETOPOSIDE CAPSULES 50MG I.S. 20S PG |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 20.000 |
Cross-references
6 manufacturer part numbers on file for this NSN — each shown against the CAGE code it belongs to.
| Manufacturer part number | CAGE |
|---|---|
| 3091-45 | 29398 |
| VEPESID | 29398 |
| NDC00015-3091-45 | 29398 |
| VEPESID CAPSULES | 29398 |
| 19-001-3117 | INTE9 |
| VEPESID 50 MG CAPSULAS | 006XK |